Year: 2010
Type: review
Abstract: Histone deacetylase inhibitors (HDACi) induce a plethora of molecular and extracellular effects that singly, or in combination, result in potent anti-cancer activities. The clinical development of HDACi has been rapid, but fundamental questions about the mechanisms of anticancer activity remain: which HDAC(s) must be targeted to mediate the observed anticancer effects? Which molecular processes (ie chromatin remodeling, regulation of transcription factors, acetylation of non-histone targets) are critical? Finally, is apoptosis, differentiation or another biological effect responsible for the clinical responses we see? While it is clear that HDACi induce apoptosis associated with altered transcription of proteins involved in the intrinsic and extrinsic pathways, other mechanisms are in play, such as those relating to the aggresome/proteasome system. Through hyperacetylation of histone and non-histone targets, HDACi can induce quite diverse cellular effects. These include: altering immune responses through effects on the host and/or target cells; inducing permanent (i.e. senescence) or temporary (quiescence) cell cycle arrest usually at the G1/S transition; inhibiting angiogenesis; inhibiting apoptosis; and autophagy [ 1 – 5 ]. HDACi not only induce injury to the cell, they also modulate its ability to respond to stressful stimuli. Moreover, the anti-tumor effect is due to targeting not only the tumor cell itself, but also the tumor microenvironment and the immune milieu.
Source: Investigational New Drugs
Institutions: The University of Melbourne, Peter MacCallum Cancer Centre
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: histone deacetylase inhibitors, anticancer mechanism, histone acetylation, non-histone protein acetylation, chromatin remodeling, transcription factor regulation, apoptosis, cell cycle arrest, senescence, angiogenesis inhibition, autophagy, tumor microenvironment, immunomodulation, proteasome
Open Access status: hybrid
Estimated APC paid: $4,690
OpenAlex ID: W2095160131
